GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Common Stock

PharmaTher Holdings (XCNQ:PHRM) Common Stock : C$8.44 Mil (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Common Stock?

PharmaTher Holdings's quarterly common stock stayed the same from Aug. 2023 (C$8.44 Mil) to Nov. 2023 (C$8.44 Mil) and stayed the same from Nov. 2023 (C$8.44 Mil) to Feb. 2024 (C$8.44 Mil).

PharmaTher Holdings's annual common stock increased from May. 2021 (C$2.37 Mil) to May. 2022 (C$8.44 Mil) but then stayed the same from May. 2022 (C$8.44 Mil) to May. 2023 (C$8.44 Mil).


PharmaTher Holdings Common Stock Historical Data

The historical data trend for PharmaTher Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Common Stock Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Common Stock
2.37 8.44 8.44

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 8.44 8.44 8.44 8.44

PharmaTher Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines